As of 2024-12-12, the EV/EBITDA ratio of Quantum Genomics SA (ALQGC.PA) is -0.72. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALQGC.PA's latest enterprise value is 6.70 mil EUR. ALQGC.PA's TTM EBITDA according to its financial statements is -9.35 mil EUR. Dividing these 2 quantities gives us the above ALQGC.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.7x - 9.4x | 8.6x |
| Forward P/E multiples | 7.7x - 9.4x | 8.6x |
| Fair Price | (1.05) - (1.29) | (1.17) |
| Upside | -1561.3% - -1884.8% | -1723.1% |
| Date | EV/EBITDA |
| 2024-10-24 | -0.72 |
| 2024-10-23 | -0.73 |
| 2024-10-22 | -0.75 |
| 2024-10-21 | -0.72 |
| 2024-10-18 | -0.74 |
| 2024-10-17 | -0.72 |
| 2024-10-16 | -0.73 |
| 2024-10-15 | -0.75 |
| 2024-10-14 | -0.73 |
| 2024-10-11 | -0.76 |
| 2024-10-10 | -0.76 |
| 2024-10-09 | -0.75 |
| 2024-10-08 | -0.81 |
| 2024-10-07 | -0.80 |
| 2024-10-04 | -0.75 |
| 2024-10-03 | -0.77 |
| 2024-10-02 | -0.84 |
| 2024-10-01 | -0.86 |
| 2024-09-30 | -0.89 |
| 2024-09-27 | -0.76 |
| 2024-09-26 | -0.37 |
| 2024-09-25 | -0.38 |
| 2024-09-24 | -0.40 |
| 2024-09-23 | -0.40 |
| 2024-09-20 | -0.40 |
| 2024-09-19 | -0.34 |
| 2024-09-18 | -0.29 |
| 2024-09-17 | -0.29 |
| 2024-09-16 | -0.28 |
| 2024-09-13 | -0.30 |